SELLAS Life Sciences Group Debt to Equity Ratio Insights

SELLAS Life Sciences Group Inc (SLS)

0.92 +0.02 (+2.15%) USD | NASDAQ | Dec 23, 15:10

Debt to Equity Ratio Chart

View Debt to Equity Ratio for SLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Debt to Equity Ratio Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition

Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks

Start Trial

Microbot Medical Inc	--
Alaunos Therapeutics Inc	--
Galectin Therapeutics Inc	--
Oragenics Inc	--
Anavex Life Sciences Corp	--

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	26.50M
Total Liabilities (Quarterly)	10.61M
Shareholders Equity (Quarterly)	15.89M